Nanoparticle-drug conjugates represent a convergence of nanotechnology and pharmacology, designed to improve the selectivity, pharmacokinetics and therapeutic index of anticancer agents. By covalently ...

Oligonucleotide-conjugated antibodies have gained importance for their use in protein diagnostics. The possibility to transfer the readout signal from the protein to the DNA level with an ...

Antibody-based cancer therapies have clear advantages over chemotherapeutic drugs thanks to their high specificity and low risk of side effects. However, it can be difficult to identify targetable ...